COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Cirius Therapeutics is a clinical-stage pharmaceutical company developing MSDC-0602K, a second-generation insulin sensitizer in an actively enrolling Phase 2b Emminence trial for NASH and liver fibrosis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors